Fermenta Biotech Limited (BOM:506414)
458.25
+8.85 (1.97%)
At close: Aug 17, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 13.14 billion as of August 17, 2026. Its market cap has increased by 24.35% in one year.
Market Cap
13.14B
Enterprise Value
13.89B
Revenue
5.11B
Ranking
n/a
PE Ratio
22.47
Stock Price
458.25
ChartMarket Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 13.14B, an increase of 3,812.56%. That is a compound annual growth rate of 13.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 13.14B | 28.28% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 18.21B |
| TTK Healthcare | 16.40B |
| Amrutanjan Health Care | 14.30B |
| Syncom Formulations (India) | 14.02B |
| Lincoln Pharmaceuticals | 12.28B |
| Kopran | 9.64B |
| Bharat Parenterals | 9.30B |
| Wanbury | 9.13B |